Efficacy and safety of adjunctive orexin receptor antagonist therapy in major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
- DOI
- 10.1016/j.jad.2026.122139
- Published
- 2026 Nov 1
- Container
- Journal of affective disorders
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jad.2026.122139,
title = {Efficacy and safety of adjunctive orexin receptor antagonist therapy in major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.},
author = {Pereira SIDS and Kotochinsky M and Amador WFO and Alessi MR and Fonseca PEO and Fidelis AMF and Barroso D and Sherpa NN and Lezana AG},
year = {2026},
journal = {Journal of affective disorders},
doi = {10.1016/j.jad.2026.122139},
url = {https://doi.org/10.1016/j.jad.2026.122139}
}RIS
TY - JOUR TI - Efficacy and safety of adjunctive orexin receptor antagonist therapy in major depressive disorder: A systematic review and meta-analysis of randomized controlled trials. AU - Pereira SIDS AU - Kotochinsky M AU - Amador WFO AU - Alessi MR AU - Fonseca PEO AU - Fidelis AMF AU - Barroso D AU - Sherpa NN AU - Lezana AG PY - 2026 JO - Journal of affective disorders DO - 10.1016/j.jad.2026.122139 UR - https://doi.org/10.1016/j.jad.2026.122139 ER -
APA
SIDS, P., M, K., WFO, A., MR, A., PEO, F., AMF, F., D, B., NN, S., & AG, L. (2026). Efficacy and safety of adjunctive orexin receptor antagonist therapy in major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.. Journal of affective disorders. https://doi.org/10.1016/j.jad.2026.122139
Source records
- pubmed · retrieved 2026-09-25T06:45:09.909Z